PDCD1 and cancer: Increasing research has discovered that tumors maintain a state of T cell exhaustion through PD1 signaling, blocking the PD-1 signaling pathway restores or reverses the activity and immune function of exhausted T cells to some extent, enhancing the effectiveness of cancer immunotherapy [77, 166, 167].